The First One

The National Center for Advancing Translational Sciences is embarking on its first clinical trial, reports the Nature News Blog. The trial is examining a drug, called DEX-M74, for hereditary inclusion body myopathy, a condition that strikes young adults and for which there is no treatment, a press release adds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

An NCATS License

Share It All

To Court

And the Result Is…

To Work Toward

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.